Sequencing Targeted and Immune Therapy in BRAF-Mutant Melanoma: Lessons Learned
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Sequencing Targeted and Immune Therapy in BRAF-Mutant Melanoma: Lessons Learned ; volume:25 ; number:6 ; day:30 ; month:3 ; year:2023 ; pages:623-634 ; date:6.2023
Current oncology reports ; 25, Heft 6 (30.3.2023), 623-634, 6.2023
- Urheber
-
Trojaniello, Claudia
Sparano, Francesca
Cioli, Eleonora
Ascierto, Paolo Antonio
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11912-023-01402-8
- URN
-
urn:nbn:de:101:1-2023090610383583251653
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Trojaniello, Claudia
- Sparano, Francesca
- Cioli, Eleonora
- Ascierto, Paolo Antonio
- SpringerLink (Online service)
Ähnliche Objekte (12)
Stopping targeted therapy for complete responders in advanced BRAF mutant melanoma
Optimizing the treatment of BRAF mutant melanoma
Novel combination therapies for BRAF-mutant melanoma
Polyamine and EIF5A hypusination downstream of c-Myc confers targeted therapy resistance in BRAF mutant melanoma
WNT5A-ROR2 axis mediates VEGF dependence of BRAF mutant melanoma
Inhibition of mitochondrial respiration prevents BRAF-mutant melanoma brain metastasis
ROCK 1 is a potential combinatorial drug target for BRAF mutant melanoma
Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma
ERK-mediated phosphorylation regulates SOX10 sumoylation and targets expression in mutant BRAF melanoma
Characterization of the impact of BRAF-targeted inhibition in the melanoma microenvironment
BRAF V600E-Mutant Glioblastoma with Extracranial Metastases Responsive to Combined BRAF and MEK Targeted Inhibition: A Case Report
Cost-effectiveness of immune checkpoint inhibition and targeted treatment in combination as adjuvant treatment of patient with BRAF-mutant advanced melanoma
Stopping targeted therapy for complete responders in advanced BRAF mutant melanoma
Optimizing the treatment of BRAF mutant melanoma
Novel combination therapies for BRAF-mutant melanoma
Polyamine and EIF5A hypusination downstream of c-Myc confers targeted therapy resistance in BRAF mutant melanoma
WNT5A-ROR2 axis mediates VEGF dependence of BRAF mutant melanoma
Inhibition of mitochondrial respiration prevents BRAF-mutant melanoma brain metastasis
ROCK 1 is a potential combinatorial drug target for BRAF mutant melanoma
Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma
ERK-mediated phosphorylation regulates SOX10 sumoylation and targets expression in mutant BRAF melanoma
Characterization of the impact of BRAF-targeted inhibition in the melanoma microenvironment
BRAF V600E-Mutant Glioblastoma with Extracranial Metastases Responsive to Combined BRAF and MEK Targeted Inhibition: A Case Report
Cost-effectiveness of immune checkpoint inhibition and targeted treatment in combination as adjuvant treatment of patient with BRAF-mutant advanced melanoma
Stopping targeted therapy for complete responders in advanced BRAF mutant melanoma
Optimizing the treatment of BRAF mutant melanoma
Novel combination therapies for BRAF-mutant melanoma
Polyamine and EIF5A hypusination downstream of c-Myc confers targeted therapy resistance in BRAF mutant melanoma
WNT5A-ROR2 axis mediates VEGF dependence of BRAF mutant melanoma
Inhibition of mitochondrial respiration prevents BRAF-mutant melanoma brain metastasis
ROCK 1 is a potential combinatorial drug target for BRAF mutant melanoma
Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma
ERK-mediated phosphorylation regulates SOX10 sumoylation and targets expression in mutant BRAF melanoma
Characterization of the impact of BRAF-targeted inhibition in the melanoma microenvironment
BRAF V600E-Mutant Glioblastoma with Extracranial Metastases Responsive to Combined BRAF and MEK Targeted Inhibition: A Case Report